In the second quarter, J&J’s worldwide oncology sales shot up more than 20 per cent, offsetting declines in sales of its ...

President Trump has flagged that US tariffs on pharmaceutical imports are likely to kick in on Aug. 1, with duties on ...

In its Q2 earnings call Thursday, Novartis said it is moving quickly to reshore its drug manufacturing operations, but CEO ...

President Trump announced potential tariffs on imported pharmaceuticals by month's end, followed by semiconductor levies.

At a Cabinet meeting earlier this month, Trump said that he expected pharmaceutical tariffs to grow as high as 200% after ...

Johnson & Johnson halved its expectations for costs this year related to new tariffs and raised its full-year sales and ...

The sector-specific tariffs are putting pressure on businesses and foreign nations as they try to navigate Trump’s constantly ...

Trump plans steep tariffs on pharmaceuticals and semiconductors by July-end, eyes India trade deal as part of broader ...

Australia is “urgently seeking more detail” on U.S. President Donald Trump’s threat to raise tariffs up to 200% on ...

Donald Trump again has threatened a tariff on imported drugs, but has given the drug makers a year or so "to get their act ...

J&J raised its 2025 adjusted profit and sales forecasts, driven by strong demand for its cancer drugs, such as Darzalex, and ...